No Detail Found!

Insights into Acute Myeloid Leukemia: Critical Analysis on its Wide AspectsInsights into Acute Myeloid Leukemia: Critical Analysis on its Wide AspectsInsights into Acute Myeloid Leukemia: Critical Analysis on its Wide Aspects

Author(s)
Mudassir Khan Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, Pakistan
Misbahud Din Department of Biotechnology, Quaid-i-Azam University Islamabad, Pakistan
Zerbab Naeem Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, Pakistan
Zahra Sajid Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, Pakistan
Dilawar Khan Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, Pakistan
Muhammad Dawood Amjad Department of Healthcare Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Science and Technology (NUST), Islamabad, Pakistan
Aurang Zeb School of Biology and Basic Medical Sciences Soochow University, Suzhou, China
Faheem Anwar Department of Genetics, Hazara University, Mansehra, Pakistan
Mehran Akhtar Department of Biotechnology, COMSATS University Islamabad, Abbottabad Campus, Pakistan
Sana Noreen University Institute of Diet and Nutritional Sciences, The University of Lahore, Pakistan
Abstract
Acute myeloid leukaemia (AML) is a heterogeneous, most common type of acute leukaemia that involves mutation in haematopoietic and progenitors stem cells (HPSCs) leading to uncontrolled division, self-renewal and differentiation. Though it was untreatable about a half century ago, AML is now considered to be treatable in up to 40% of adults and those who are at or under 60 years of age. For the post-induction treatment, the mutation testing and cytogenetics are still an important prognostic tool. The AML treatment remains unchanged for almost three decades, although the field is advanced with the discovery of new drugs and deep understanding of the disease biology. Still, many people are relapsing and are dying eventually from the disease. This review discusses the broader aspects of AML, reflecting some of the most important and productive areas of research on the subject and was conducted using thoroughly searching databases, including Health Research and Development Information network Plus (HERDIN Plus), google scholar and PubMed to critically analyses the recent advances, available treatments and future prospectives of AML.
Publication Details
Page(s) 1-9
Published Journal: Abasyn Journal of Life Sciences, Volume: 3, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
pathogenesis, Relapse, treatment, AML
0

Citations

0

Downloads

87

Views